Congo, Democratic Republic of the vs Uzbekistan: HIV-positive TB patients on ART (antiretroviral therapy)
Congo, Democratic Republic of the
90.0%
in 2024
Uzbekistan
89.0%
in 2023
Congo, Democratic Republic of the rank
94th
Uzbekistan rank
96th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Congo, Democratic Republic of the
- Uzbekistan
How they compare
Congo, Democratic Republic of the currently reports 90.0% against 89.0% in Uzbekistan, a difference of 1.0%.
The two have swapped places 10 times across 18 shared years of data; in 2006 it was Congo, Democratic Republic of the ahead.
Congo, Democratic Republic of the ranks 94th and Uzbekistan ranks 96th of 144 countries.
Congo, Democratic Republic of the has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.8% | 11.9% | 18.9% | Congo, Democratic Republic of the |
| 2010s | 59.4% | 56.7% | 2.7% | Congo, Democratic Republic of the |
| 2020s | 87.2% | 83.0% | 4.2% | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Congo, Democratic Republic of the or Uzbekistan?
- Congo, Democratic Republic of the, at 90.0% against 89.0% in Uzbekistan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Congo, Democratic Republic of the and Uzbekistan?
- 1.0%, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Uzbekistan?
- 18 years are reported by both, from 2006 to 2023.
- How do Congo, Democratic Republic of the and Uzbekistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Congo, Democratic Republic of the ranks 94th and Uzbekistan ranks 96th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.